Advertisement

Topics

FDA Approves Tecovirimat, First Drug for Smallpox Treatment

12:39 EDT 13 Jul 2018 | Medscape

Tecovirimat (TPOXX) provides a treatment option should smallpox ever be used as a bioweapon and is the first product to be awarded a material threat medical countermeasure priority review voucher.
FDA Approvals

Original Article: FDA Approves Tecovirimat, First Drug for Smallpox Treatment

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Tecovirimat, First Drug for Smallpox Treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...